Mantle

Josefin Landgård grew up in northern Sweden as an elite competitive skier, her face perpetually scoured by mountain wind and sub-zero air, which left her preoccupied with what genuinely protects skin under stress. That preoccupation arrived only after a first career in healthtech: she sat on the founding team of telemedicine company KRY (Livi abroad), later steered the subscription beauty service Glossybox as chief executive, and spent years building digital-health businesses before turning to formulation. The pivot was personal as much as strategic. A punishing startup cycle, a separation, two young children and chronic insomnia sent her looking for a calming aid, and a trip through New York, where cannabidiol was suddenly infused into everything from seltzer to serums, planted the idea that it might belong in skincare too.

What distinguishes the line is a refusal to treat one buzzy molecule as the whole proposition. Landgård and co-founder Stina Lönnkvist diagnosed a gap between cold, clinical brands and warm-but-flimsy natural ones, and built formulas to bridge it. Each product is field-tested in genuine Nordic extremes, down toward minus fifteen degrees, in a northern Swedish lab rather than a marketing department. The catalog reaches well past its calming reputation: a Longevity Serum leaning on EGF and orchid stem cells, the niacinamide-and-bakuchiol Glow Serum, the overnight Dream Mask that became the breakout hit, plus richer creams and essences for barrier repair.

Investors have backed the thesis. A 2024 round led by British venture firm Venrex brought roughly 2.4 million pounds, lifting total funding near 6.9 million and financing expansion across Europe and toward the United States, with a team reported as overwhelmingly female. The honest caveat survives the growth: the surrounding actives are the proven workhorses, and the cannabidiol remains the part of the formula asking shoppers for the most faith.

Sources:[1][2][3][4]